MTOR and neoplasm: To sum up, our data demonstrate an enhanced radiosensitivity in tumor cells pretreated simultaneously with PI3K/mTOR and Hsp90 inhibitors shortly before IR compared with the cells treated with Hsp90 inhibitor alone.